Antonello Pessi

Rome, 00144, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and Diabetes.

Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and Diabetes.

Journal: ACS medicinal chemistry letters

Published: May 09, 2022

Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.

Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.

Journal: Antiviral research

Published: June 09, 2019

Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity.

Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity.

Journal: Scientific reports

Published: February 21, 2019

Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells.

Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 23, 2017

Polypharmacy through Phage Display: Selection of Glucagon and GLP-1 Receptor Co-agonists from a Phage-Displayed Peptide Library.

Polypharmacy through Phage Display: Selection of Glucagon and GLP-1 Receptor Co-agonists from a Phage-Displayed Peptide Library.

Journal: Scientific reports

Published: July 13, 2017

A first-in-human study of the novel HIV-fusion inhibitor C34-PEG4-Chol.

A first-in-human study of the novel HIV-fusion inhibitor C34-PEG4-Chol.

Journal: Scientific reports

Published: October 27, 2016

Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.

Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.

Journal: Scientific reports

Published: October 14, 2016

Host defense peptide-derived privileged scaffolds for anti-infective drug discovery.

Host defense peptide-derived privileged scaffolds for anti-infective drug discovery.

Journal: Journal of peptide science : an official publication of the European Peptide Society

Published: October 12, 2016

Lipophilicity is a key factor to increase the antiviral activity of HIV neutralizing antibodies.

Lipophilicity is a key factor to increase the antiviral activity of HIV neutralizing antibodies.

Journal: Colloids and surfaces. B, Biointerfaces

Published: October 04, 2016

Design and activity of a cyclic mini-β-defensin analog: a novel antimicrobial tool.

Design and activity of a cyclic mini-β-defensin analog: a novel antimicrobial tool.

Journal: International journal of nanomedicine

Published: October 29, 2015

An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule.

An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule.

Journal: Scientific reports

Published: October 05, 2015

Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin.

Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin.

Journal: Journal of peptide science : an official publication of the European Peptide Society

Published: February 19, 2015

Showing 1-12 of 25

Last Updated: 09/26/2026